Enspire Medical

Enspire Medical is a neurotechnology company headquartered in San Jose, California, developing next-generation implantable devices for neuromodulation therapy. The company specializes in sacral neuromodulation (SNM), a clinically proven approach to treating overactive bladder and bowel dysfunction by modulating nerve activity through precisely targeted electrical stimulation. Their flagship device distinguishes itself through innovative wireless recharging technology and Bluetooth-enabled patient controls, enabling seamless management and personalization of therapy directly from a smartphone or dedicated application.

The company has achieved significant validation in the competitive neuromodulation market, having secured Series A funding of $18 million to advance product development and clinical pathways. This funding milestone demonstrates investor confidence in Enspire's technology platform and market opportunity, as they position themselves to compete against established players in the sacral neuromodulation space. The capital infusion enables the company to accelerate regulatory approvals, expand manufacturing capabilities, and bring their advanced device platform to patients who currently rely on older generation technology.

Enspire Medical represents an important evolution in the neuromodulation industry by integrating modern connectivity and user experience into traditionally complex implantable therapies. By prioritizing wireless recharging and Bluetooth functionality, the company addresses long-standing patient pain points around device maintenance and therapy optimization, setting new standards for convenience and control in neuromodulation. Their innovations underscore a broader industry shift toward patient-centric implantable devices that leverage digital health integration while maintaining the clinical efficacy that defines effective neuromodulation therapy.